Clinical Trial Highlights - GLP-1 agonists

J Parkinsons Dis. 2020;10(2):355-368. doi: 10.3233/JPD-200002.
No abstract available

MeSH terms

  • Animals
  • Clinical Trials as Topic*
  • Exenatide / pharmacology*
  • Glucagon-Like Peptide-1 Receptor Agonists*
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • Neuroprotective Agents / pharmacology*
  • Parkinson Disease / drug therapy*

Substances

  • Hypoglycemic Agents
  • Neuroprotective Agents
  • Exenatide
  • Glucagon-Like Peptide-1 Receptor Agonists